Physicochemical properties and dissolution studies of dexamethasone acetate-β-cyclodextrin inclusion complexes produced by different methods

AAPS PharmSciTech

Volumn 9, Issue 1, 2008, Pages 314-321

  Doile, Mayara M ^a   Fortunato, Keila A ^a   Schmücker, Iára C ^a   Schucko, Sacha K ^a   Silva, Marcos A S ^b   Rodrigues, Patrik O ^a,b  

^a UNIVERSITY OF JOINVILLE REGION   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

cyclodextrin; Dexamethasone acetate; Dissolution rate; Inclusion complexes; Phase solubility; Physicochemical characterization

Indexed keywords

BETA CYCLODEXTRIN; DEXAMETHASONE ACETATE; WATER; BETA CYCLODEXTRIN DERIVATIVE; DEXAMETHASONE; DRUG CARRIER; DRUG DERIVATIVE;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; FREEZE DRYING; INFRARED SPECTROSCOPY; INTESTINE FLUID; MICROSCOPY; PHYSICAL CHEMISTRY; SIMULATION; STOICHIOMETRY; STOMACH JUICE; THERMOGRAVIMETRY; THERMOSTABILITY; CHEMISTRY; DRUG SCREENING; MATERIALS TESTING; SOLUBILITY;

BETA-CYCLODEXTRINS; DEXAMETHASONE; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; GASTRIC JUICE; MATERIALS TESTING; SOLUBILITY;

EID: 44849129783     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-008-9042-z     Document Type: Article

References (23)

1. S. A. Mitchell, T. D. Reynolds, and T. P. Dasbach. A compaction process to enhance dissolution of poorly water-soluble drugs using hydroxypropyl methylcellulose. Int. J. Pharm. 250: 3-11 (2003).
2. R. Ficarra, P. Ficarra, and M. R. D. Bella. Study of the inclusion complex of atenolol with β-cyclodextrins. J. Pharm. Biomed. Anal. 23: 231-6 (2000).
3. G. Zingone, and F. Rubessa. Preformulation study of the inclusion complex warfarin-B-cyclodextrin. Int. J. Pharm. 291: 3-10 (2005).
4. M. N. Reddy, T. Rehana, S. Ramakrishna, K. P. R. Chowdary, and P. V. Diwan. b-Cyclodextrin Complexes of Celecoxib: Molecular-Modeling, Characterization, and Dissolution studies. AAPS PharmSci. 6: Article 7. (2004)
5. L. P. Ruan, B. Y. Yu, G. M. Fu, and D. Zhu. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes. J. Pharm. Biomed. Anal. 38: 457-464 (2005).
6. L. Van Santvliet, K. Caljon, L. Pieters, and A. Ludwig. Physicochemical properties, NMR spectroscopy and tolerance of inclusion complexes of antazoline and tetracaine with hydroxypropyl-β-cyclodextrin. Int. J. Pharm. 171: 147-156 (1998).
7. J. L. Manzoori, H. A. Zadeh, and M. Amjadi. Study on the complex between B-cyclodextrin and celecoxib by spectrofluorimetry and its analytical application. Il Farmaco. 60: 575-581 (2005).
8. N. Zerrouk, G. M. Ginès Dorado, P. Arnaud, and C. Chemtob. Physical characteristics of inclusion compounds of 5-ASA in α and β cyclodextrins. Int. J. Pharm. 171: 19-29 (1998).
9. R. F. L. Vianna, M. V. L. B. Bentley, G. Ribeiro et al. Formation of cyclodextrin inclusion complexes with corticosteroids: Their characterization and stability. Int. J. Pharm. 167: 205-213 (1998).
10. D. C. Bibby, N. M. Davies, and I. G. Tucker. Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. Int. J. Pharm. 197: 1-11 (2000).
11. K. Uekama, F. Hirayama, and T. Irie. Cyclodextrin drug carrier systems. Chem. Rev. 98: 2045-2076 (1998).
12. M. Singh, R. Sharma, and U. C. Banerjee. Biotechnological applications of cyclodextrins. Biotechnol. Adv. 20: 341-359 (2002).
13. S. Rawat, and S. K. Jain. Solubility enhancement of celecoxib using β-cyclodextrin inclusion complexes. Eur. J. Pharm. Biopharm. 57: 263-267 (2004).
14. K. J. Waleczek, H. M. Cabral Marques, B. Hempel, and P. C. Schimidt. Phase solubility studies of pure (̄)-α-bisabolol and camomile essential oil with β-cyclodextrin. Eur. J. Pharm. Biopharm. 55: 247-251 (2003).
15. C. V. P. Rossel, J. S. Carreño, M. R. Baeza, and J. B. Alderete. Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase. Quim. Nova. 23: 749-752 (2000).
16. L. S. Koester, C. R. Xavier, P. Mayorga, and V. L. Bassani. Influence of β-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets. Eur. J. Pharm. Biopharm. 55: 85-91 (2003).
17. H. Aki, T. Niiya, Y. Iwase, Y. Kawasaki, K. Kumai, and T. Kimura. Multimodal inclusion complexes of ampicillin with β-cyclodextrins in aqueous solution. Thermochim. Acta. 416: 87-92 (2004).
18. K. Rajendrakumar, S. Madhusudan, and T. Pralhad. Cyclodextrin complexes of valdecoxib: Properties and anti-inflammatory activity in rat. Eur. J. Pharm. Biopharm. 60: 39-46 (2005).
19. D. H. Kim, and D. C. Martin. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. Biomaterials 27: 3031-3037 (2006).
20. T. Higuchi, and K. A. Connors. Phase solubility techniques. Adv. Anal. Chem. Instrum. 4: 117-212 (1965).
21. The United States Pharmacopeia (USP) 26, NF 21, United States Pharmacopeial Convention Inc. Rockville, MD; 2003.
22. L. Liu, and S. Zhu. Preparation and characterization of inclusion complexes of prazosin hydrochloride with β-cyclodextrin and hydroxypropyl-β-cyclodextrin. J. Pharm. Biomed. Anal. 40: 122-127 (2006).
23. M. Krueger. Clarke's Analysis of Drugs and Poisons. Pharmaceutical Press Software; 200